Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.46 |
| ▸ | DNM2 | P50570 | 4/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.42 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.38 |
| ▸ | CYP4Z1 | Q86W10 | 4/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3689385 | 0.98 | DNM2 (0.47) | TLR8DNM2SOAT1HCAR3CYP4Z1 | |
| SCHEMBL28859627 | 0.98 | DNM2 (0.47) | TLR8DNM2SOAT1HCAR3CYP4Z1 | |
| SCHEMBL1638321 | 0.83 | TLR8 (0.34) | TLR8DNM2SOAT1HCAR3CYP4Z1 | |
| SCHEMBL17927689 | 0.79 | SOAT1 (0.46) | TLR8DNM2SOAT1HCAR3KCNH3 | |
| SCHEMBL28163938 | 0.77 | SOAT1 (0.48) | TLR8DNM2SOAT1HCAR3KCNH3 | |
| SCHEMBL4099219 | 0.76 | KDM4E (0.40) | LMNASMN1; SMN2 | |
| SCHEMBL13356938 | 0.73 | TLR8 (0.47) | TLR8SOAT1HCAR3LMNASMN1; SMN2 | |
| SCHEMBL18641559 | 0.72 | TLR8 (0.33) | TLR8HCAR3 | |
| SCHEMBL23768365 | 0.71 | SOAT1 (0.49) | TLR8DNM2SOAT1HCAR3 | |
| SCHEMBL3662937 | 0.71 | DNM2 (0.50) | TLR8DNM2SOAT1HCAR3S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354097-B2 | Cosmetic composition forming after application a supramolecular polymer | L'OREAL (FR) | 2013-01-15 | — | — | US | claimed |
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2012-02-02 | — | — | US | claimed |
| US-7862805-B2 | Cosmetic composition forming after application a supramolecular polymer | L'OREAL (FR) | 2011-01-04 | — | — | US | claimed |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2010-11-04 | — | — | US | claimed |
| US-20100242188-A1 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'OREAL S.A. (FR) | 2010-09-30 | — | — | US | claimed |
| US-20100247466-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2010-09-30 | — | — | US | claimed |
| EP-2083791-A2 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'Oreal (FR) | 2009-08-05 | — | — | EP | claimed |
| EP-1768644-B1 | LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS | CIBA HOLDING INC (CH) | 2009-02-18 | — | — | EP | claimed |
| WO-2008059125-A2 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'OREAL (FR) | 2008-05-22 | — | — | WO | claimed |
| US-20070264208-A1 | Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process | L'OREAL S.A. (FR) | 2007-11-15 | — | — | US | claimed |
| EP-1797868-A1 | Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | claimed |
| EP-1797867-A1 | Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | claimed |
| JP-2006505514-A | — | — | 2006-02-16 | — | — | JP | claimed |
| US-20050267109-A1 | Pyridyl-triazine derivatives as microbiocidal active substances | CIBA SPECIALTY CHEMICALS CORP. | 2005-12-01 | — | — | US | claimed |
| JP-2005520777-A | — | — | 2005-07-14 | — | — | JP | claimed |
| EP-1525196-A1 | PYRIDYL-TRIAZINE DERIVATIVES AS MICROBICIDAL ACTIVE SUBSTANCES | Ciba SC Holding AG (CH) | 2005-04-27 | — | — | EP | claimed |
| US-20040161394-A1 | Cosmetic composition forming after application a supramolecular polymer | L'OREAL (FR) | 2004-08-19 | — | — | US | claimed |
| EP-1392222-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2004-03-03 | — | — | EP | claimed |
| WO-2004013124-A1 | PYRIDYL-TRIAZINE DERIVATIVES AS MICROBICIDAL ACTIVE SUBSTANCES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-02-12 | — | — | WO | claimed |
| WO-2002098377-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2002-12-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070264208-A1 | Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process | KRT18, DSG1, DSC1 | TLR8 3680/4885DNM2 2766/4885SOAT1 2624/4885 |
| US-20100242188-A1 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | KRT18, S100A6, IK | TLR8 4213/4885DNM2 3139/4885SOAT1 3794/4885 |
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | TLR8 3855/4885DNM2 2700/4885SOAT1 2599/4885 |
| US-20040161394-A1 | Cosmetic composition forming after application a supramolecular polymer | KRT18, DSG1, CUTA | TLR8 2540/4885DNM2 1079/4885SOAT1 2859/4885 |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | TLR8 3855/4885DNM2 2700/4885SOAT1 2599/4885 |
| US-20100247466-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | KRT18, CUTA, DSG1 | TLR8 2682/4885DNM2 1019/4885SOAT1 2740/4885 |
| US-20050267109-A1 | Pyridyl-triazine derivatives as microbiocidal active substances | C3AR1, C1S, C5 | TLR8 1469/4885DNM2 2024/4885SOAT1 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.